Increase of inquiry in the field of propylene glycol raw materials
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dow's Thailand Map Ta Phut Propylene Glycol Plant Receives ISCC PLUS Certification
-
ECHEMI High Quality Inquiries (27-31 July)
-
ECHEMI High Quality Inquiries (1-5 July)
-
2024 ECHEMI International Match Meeting of Chemical Raw Materials
-
2024 ECHEMI International Match Meeting of Chemical Raw Materials
-
Price increase! Raw materials soared 10%, price letter to the factory in advance!
-
Kiehl's Dermatologist Solutions Powerful-strength Line-reducing Concentrate
-
Dow and Evonik Initiate Operations of Pilot Plant Converting Hydrogen Peroxide to Propylene Glycol
-
Leakage Accident Turns Pristine Waters of Nago, Japan into Red: Propylene Glycol Safety Concerns Arise
-
BASF to build neopentyl glycol plant at Zhanjiang integration site
Recommend Reading
-
SkinCeuticals Unveils AGE Interrupter Ultra Serum to Target Skin Laxity
-
Symrise Opens New Production Unit in Granada to Ensure Safer Supply of Bio-Based Pentylene Glycol
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations
-
Safic-Alcan Acquires Anders, Expanding Latin American Presence
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
December Phosphate Market Trends Fluctuate and Decline in China
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
MTBE Market Conditions Remain Weak
-
“An €8 Billion Loss, Yet a 25% Price Hike”: Wacker Chemie’s Contradictory Crisis—Survival Move or Desperate Gamble?
-
2025 Titanium Dioxide Market Review and 2026 Outlook